$105.00
Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. SLU-PP-332 is not approved for medical use, human consumption, or as a therapeutic treatment.
Product Details
Quantity: 5mg per vial
Purity: ≥99%, Rigorous third-party testing
Packaging: Secure, sealed, and tamper-proof vials
Source: Synthesized using advanced compound synthesis techniques. Third-party tested.
Note: This product is sold in powder form and must be reconstituted before use.
Overview
SLU-PP-332 is a potent and selective PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist that has drawn significant interest in research focused on metabolic regulation, endurance pathways, and energy utilization. Its mode of action involves activating PPARδ receptors, which play a central role in lipid metabolism and oxidative energy production.
Researchers value SLU-PP-332 for its potential to increase fatty acid oxidation, improve mitochondrial efficiency, and promote metabolic flexibility in experimental models. Its unique selectivity for PPARδ makes it an important tool in studies exploring endurance performance and advanced metabolic adaptations.
Research Specifics
Lipid Metabolism: Investigates its role in enhancing fatty acid oxidation and regulating lipid utilization.
Mitochondrial Efficiency: Studies assess its ability to optimize oxidative energy production in cells.
Endurance Pathways: Explored for its influence on stamina-related biochemical responses in controlled research environments.
Metabolic Flexibility: Evaluated for potential in shifting energy usage from carbohydrate to fat-based fuel systems.
Technical Specifications
Molecular Formula: C24H24N4O3 (may vary slightly depending on salt form)
Purity: ≥99%, Rigorous third-party testing
Form: Powder
Storage: Store at -20°C for long-term stability
Solubility: Requires reconstitution with sterile bacteriostatic water or a suitable solvent before use
Reviews
There are no reviews yet.